Group A rotaviruses (RVAs) are classified according to a nucleotide sequence-based system that assigns a genotype to each of the 11 double-stranded RNA (dsRNA) genome segments. For the segment encoding the VP1 polymerase, 22 genotypes (R1 to R22) are defined with an 83% nucleotide identity cutoff value. For the segment encoding the VP2 core shell protein, which is a functional VP1-binding partner, 20 genotypes (C1 to C20) are defined with an 84% nucleotide identity cutoff value. However, the extent to which the VP1 and VP2 proteins encoded by these genotypes differ in their sequences or interactions has not been described. Here, we sought to (i) delineate the relationships and sites of variation for VP1 and VP2 proteins belonging to the known RVA genotypes and (ii) correlate intergenotypic sequence diversity with functional VP1-VP2 interaction(s) during dsRNA synthesis. Using bioinformatic approaches, we revealed which VP1 and VP2 genotypes encode divergent proteins and identified the positional locations of amino acid changes in the context of known structural domains/subdomains. We then employed an dsRNA synthesis assay to test whether genotype R1, R2, R4, and R7 VP1 polymerases could be enzymatically activated by genotype C1, C2, C4, C5, and C7 VP2 core shell proteins. Genotype combinations that were incompatible informed the rational design and testing of chimeric mutant VP1 and VP2 proteins. The results of this study connect VP1 and VP2 nucleotide-level diversity to protein-level diversity for the first time, and they provide new insights into regions/residues critical for VP1-VP2 interaction(s) during viral genome replication. Group A rotaviruses (RVAs) are widespread in nature, infecting numerous mammalian and avian hosts and causing severe gastroenteritis in human children. RVAs are classified using a system that assigns a genotype to each viral gene according to its nucleotide sequence. To date, 22 genotypes have been described for the gene encoding the viral polymerase (VP1), and 20 genotypes have been described for the gene encoding the core shell protein (VP2). Here, we analyzed if/how the VP1 and VP2 proteins encoded by the known RVA genotypes differ from each other in their sequences. We also used a biochemical approach to test whether the intergenotypic sequence differences influenced how VP1 and VP2 functionally engage each other to mediate RNA synthesis in a test tube. This work is important because it increases our understanding of RVA protein-level diversity and raises new ideas about the VP1-VP2 binding interface(s) that is important for viral replication.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321916PMC
http://dx.doi.org/10.1128/JVI.01642-18DOI Listing

Publication Analysis

Top Keywords

vp1 vp2
28
core shell
16
vp2 proteins
16
vp2 core
12
intergenotypic sequence
12
vp1
11
vp2
11
vp1 polymerase
8
shell proteins
8
group rotaviruses
8

Similar Publications

Enteroviruses and rhinoviruses are highly diverse, with over 300 identified types. Reverse transcription-polymerase chain reaction (RT-PCR) assays targeting their VP1, VP4, and partial VP2 (VP4-pVP2) genomic regions are used for detection and identification. The VP4-pVP2 region is particularly sensitive to RT-PCR detection, making it efficient for clinical specimen analysis.

View Article and Find Full Text PDF

Physicochemical and biological impacts of light stress on adeno-associated virus serotype 6.

Mol Ther Methods Clin Dev

December 2024

Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.

Article Synopsis
  • Recombinant adeno-associated virus (rAAV) is being studied as a gene therapy vector, but its response to light exposure has not been fully understood.
  • Research on rAAV6 with EGFP showed that light stress resulted in a 20% loss of virus particles and a 90% reduction in biological activity, primarily due to DNA degradation.
  • Analysis revealed that light exposure causes specific types of protein and DNA damage, indicating the importance of careful handling and storage of rAAV to preserve its therapeutic effectiveness.
View Article and Find Full Text PDF

Novel polyomavirus in the endangered garden dormouse Eliomys quercinus.

Virol J

November 2024

Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio al. 7, Vilnius, LT-10257, Lithuania.

Article Synopsis
  • The garden dormouse's population in Europe has declined significantly due to factors like habitat loss, climate change, and potentially pathogen exposure.
  • In a study involving 89 garden dormice from Germany, researchers tested kidney samples for polyomavirus DNA and checked for antibodies in their body fluids.
  • A new polyomavirus related to other known polyomaviruses was identified, with a small percentage of dormice testing positive for the virus, suggesting that further research is needed to determine its significance and specificity to the garden dormouse.
View Article and Find Full Text PDF

Human norovirus disturbs intestinal motility and transit time through its capsid proteins.

PLoS Pathog

November 2024

KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Virus-Host Interactions & Therapeutic Approaches (VITA) Research Group, Leuven, Belgium.

Article Synopsis
  • Human norovirus (HuNoV) causes over 700 million cases of gastroenteritis yearly, leading to symptoms like vomiting and diarrhea, but the mechanisms of infection are not well understood due to the absence of suitable animal models.
  • Researchers utilized a zebrafish larvae model to investigate how HuNoV affects intestinal motility and whether a specific viral protein might act as an enterotoxin.
  • The study found that HuNoV GII.4 infection increased intestinal contraction frequency and delayed food transit time in the larvae, indicating potential effects on bowel movements, with viral proteins VP1 and VP2 playing significant roles in these symptoms.
View Article and Find Full Text PDF

Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient.

Viruses

November 2024

Department of Industrial Transformation, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming 650000, China.

Article Synopsis
  • The serotype 2 oral poliovirus vaccine (OPV2) can revert and lead to vaccine-derived poliovirus, posing a threat to eradication efforts, especially in immunocompromised individuals.
  • A study analyzed changes in specific amino acids within the virus's structure that affect its ability to be neutralized by immune serum from vaccinated individuals.
  • The findings indicate that mutations in the virus significantly reduce the effectiveness of antibodies, highlighting the need for ongoing monitoring of immunocompromised populations and maintaining high vaccination rates in these communities.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!